INTRODUCTION
============

MicroRNAs (miRNAs) are naturally occurring, highly conserved families of transcripts (18--25 nt in length) that are processed from larger hairpin precursors ([@b1],[@b2]). miRNAs are found in the genomes of animals ([@b3]--[@b9]) and plants ([@b10]--[@b12]). To date, there are ∼1000 unique transcripts, including 326 human miRNAs in the Sanger Center miRNA registry ([@b13]).

miRNAs regulate gene expression by catalyzing the cleavage of messenger RNA (mRNA) ([@b14]--[@b19]) or repressing mRNA translation ([@b19]--[@b21]). They are believed to be critical in cell development, differentiation and communication ([@b2]). Specific roles include the regulation of cell proliferation and metabolism ([@b22]), developmental timing ([@b23],[@b24]), cell death ([@b25]), haematopoiesis ([@b26]), neuron development ([@b27]), human tumorigenesis ([@b28]) and DNA methylation and chromatin modification ([@b29]).

Although miRNAs represent a relatively abundant class of transcripts, their expression levels vary greatly among species and tissues ([@b30]). Less abundant miRNAs routinely escape detection with technologies such as cloning, northern hybridization ([@b31]) and microarray analysis ([@b32],[@b33]). Here, we present a novel real-time quantification method for accurate and sensitive detection of miRNAs and other small RNAs. This method expands the real-time PCR technology for detecting gene expression changes from macromolecules (e.g. mRNAs) to micro molecules (e.g. miRNAs).

MATERIALS AND METHODS
=====================

Targets, primers and probes (Supplementary Data)
------------------------------------------------

Seventeen miRNA genes were selected from the Sanger Center miRNA Registry at <http://www.sanger.ac.uk/Software/Rfam/mirna/index.shtml>. All TaqMan miRNA assays are available through Applied Biosystems (P/N: 4365409). Standard TaqMan^®^ assays for pri-miRNA precursors, pri-let-7a-3 and pri-miR-26b and pre-miRNA precursor pre-miR-30a were designed using PrimerExpress^®^ software (Applied Biosystems, Foster City, CA). All sequences are available in the section of the Supplementary Data. Synthetic miRNA oligonucleotides were purchased from Integrated DNA Technologies (IDT, Coralville, IA).

Tissue RNA samples, cells, cell lysates and total RNA preparation
-----------------------------------------------------------------

Mouse total RNA samples from brain, heart, liver, lung, thymus, ovary and embryo at day 10--12 were purchased from Ambion (P/N: 7810, 7812, 7814, 7816, 7818, 7824, 7826 and 7968). Ambion\'s mouse total RNAs are derived from Swiss Webster mice. All RNA samples were normalized based on the TaqMan^®^ Gene Expression Assays for human or mouse glyceraldehyde-3-phosphate dehydrogenase (GAPDH) endogenous controls (P/N: 4310884E and 4352339E, Applied Biosystems).

Two cell lines, HepG2 and OP9, were cultured using Gibco MEM (P/N: 12492--021, Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS) (P/N: SH30070.01, HyClone, Logan, UT). Trypsinized cells were counted with a hemocytometer. Approximately 2.8 × 10^6^ suspended cells were pelleted by centrifugation (Allegra 6, Beckman Coulter, Fullerton, CA) at 1500 r.p.m. for 5 min, washed with 1 ml Dulbecco\'s phosphate-buffered saline (PBS) without MgCl~2~ and CaCl~2~ (P/N: 14190078, Invitrogen, Carlsbad, CA). The cell pellets were re-suspended in 140 µl PBS and processed with three different sample preparation methods. With the first method, a 50 µl sample (10^6^ cells) was mixed with an equal amount of Nucleic Acid Purification Lysis Solution (P/N: 4305895; Applied Biosystems) by pipetting up and down 10 times, and then spun briefly. The lysate was diluted 1/10 with 1 U/µl RNase inhibitor solution (P/N: N8080119; Applied Biosystems) before adding the solution to an RT reaction. In the second method, a 50 µl sample (10^6^ cells) was used to purify total RNA using the mirVana™ miRNA Isolation Kit (P/N: 1560, Ambion, Austin, TX) according to the manufacturer\'s protocol. Purified total RNA was eluted in 100 µl of elution buffer. The third method involved diluting cells 1/2 with 1× PBS, heating at 95°C for 5 min, and immediately chilling on ice before aliquotting directly into RT reactions.

miRNA detection using mirVana™ miRNA detection kit
--------------------------------------------------

Solution hybridization-based miRNA analysis was carried out using the mirVana™ miRNA Detection Kit (Cat. \#: 1552, Ambion) according to the manufacturer\'s protocol. RNA probes were synthesized by IDT. The radioisotope labeled RNA fragments were detected and quantitated with a Cyclone Storage Phosphor System (PerkinElmer, Boston, MA).

Reverse transcriptase reactions
-------------------------------

Reverse transcriptase reactions contained RNA samples including purified total RNA, cell lysate, or heat-treated cells, 50 nM stem--loop RT primer (P/N: 4365386 and 4365387, Applied Biosystems), 1× RT buffer (P/N: 4319981, Applied Biosystems), 0.25 mM each of dNTPs, 3.33 U/µl MultiScribe reverse transcriptase (P/N: 4319983, Applied Biosystems) and 0.25 U/µl RNase inhibitor (P/N: N8080119; Applied Biosystems). The 7.5 µl reactions were incubated in an Applied Biosystems 9700 Thermocycler in a 96- or 384-well plate for 30 min at 16°C, 30 min at 42°C, 5 min at 85°C and then held at 4°C. All Reverse transcriptase reactions, including no-template controls and RT minus controls, were run in duplicate.

PCR
---

Real-time PCR was performed using a standard TaqMan^®^ PCR kit protocol on an Applied Biosystems 7900HT Sequence Detection System (P/N: 4329002, Applied Biosystems). The 10 µl PCR included 0.67 µl RT product, 1× TaqMan^®^ Universal PCR Master Mix (P/N: 4324018, Applied Biosystems), 0.2 µM TaqMan^®^ probe, 1.5 µM forward primer and 0.7 µM reverse primer. The reactions were incubated in a 384-well plate at 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. All reactions were run in triplicate. The threshold cycle (*C*~T~) is defined as the fractional cycle number at which the fluorescence passes the fixed threshold. TaqMan^®^ *C*~T~ values were converted into absolute copy numbers using a standard curve from synthetic lin-4 miRNA.

The method for real-time quantification of pri-miRNA precursors, let-7a-3 and miR-26b, and pre-miRNA precursor miR-30a was described elsewhere ([@b34]).

RESULTS
=======

We proposed a new real-time RT--PCR scheme for miRNA quantification ([Figure 1](#fig1){ref-type="fig"}). It included two steps: RT and real-time PCR. First, the stem--loop RT primer is hybridized to a miRNA molecule and then reverse transcribed with a MultiScribe reverse transcriptase. Next, the RT products are quantified using conventional TaqMan PCR.

The dynamic range and sensitivity of the miRNA quantification scheme were first evaluated using a synthetic cel-lin-4 target. Synthetic RNA was quantified based on the A~260~ value and diluted over seven orders of magnitude. The cel-lin-4 TaqMan miRNA assay showed excellent linearity between the log of target input and *C*~T~ value, demonstrating that the assay has a dynamic range of at least 7 logs and is capable of detecting as few as seven copies in the PCR reaction ([Figure 2](#fig2){ref-type="fig"}).

Eight additional miRNA assays were also validated using mouse lung total RNA. The RNA input ranged from 0.025 to 250 ng ([Figure 3](#fig3){ref-type="fig"}). The *C*~T~ values correlated to the RNA input (*R*^2^ \> 0.994) over four orders of magnitude. A negative control assay, cel-miR-2, did not give a detectable signal, even in reactions with 250 ng mouse total RNA.

The expression profile of five miRNAs was determined in seven different mouse tissues to create a miRNA expression map. The copy number per cell was calculated based on the input total RNA (assuming 15 pg/cell) and the standard curve of synthetic lin-4 target. Several interesting observations were made from this expression map. First, miRNAs are very abundant, averaging 2390 copies per cell in these tissues. The level of expression ranged from less than 10 to 32 090 copies per cell. Of the 12 miRNAs, miR-16 and miR-323 were the most and least abundant miRNAs, respectively, across all tissues. In addition, each tissue had a distinctive signature of miRNA expression. The overall level of miRNA expression was highest in mouse lung and lowest in embryos. Finally, the dynamic range of miRNA expression varied greatly from less than 5-fold (let-7a) to more than 2000-fold (miR-323) among these seven tissues ([Table 1](#tbl1){ref-type="table"}).

To assess the need for RNA isolation, we added cell lysates directly to miRNA assays. The equivalent of 2.5--2500 cells were added directly to 7.5 µl RT reactions. When detected, the *C*~T~ values correlated (*R*^2^ \> 0.998) to the number of cells in the RT reactions over at least three orders of magnitude ([Figure 4](#fig4){ref-type="fig"}).

The effect of non-specific genomic DNA on TaqMan miRNA assays was also tested for 12 assays. Results showed no difference in *C*~T~ values in the presence or absence of 5 ng of human genomic DNA added to the RT reactions, suggesting that the assays are highly specific for RNA targets (data not shown). Based on this observation, we added heat-treated cells directly to miRNA quantification assays. [Figure 5](#fig5){ref-type="fig"} illustrates the comparison of miRNA quantification using purified total RNA, cell lysates and heat-treated cells derived from an equal number of HepG2 cells. Adding heat-treated cells directly to the miRNA assays produced the lowest *C*~T~ values, and good concordance was observed among all three different sample preparation methods.

The reproducibility of TaqMan miRNA assays was examined by performing12 miRNA assays with 16 replicates performed by two independent operators (data not shown). The standard deviation of the *C*~T~s averaged 0.1, demonstrating the high precision of the assays.

Solution hybridization-based miRNA northern analysis was used as an independent technology to compare with TaqMan miRNA assays ([Figure 6](#fig6){ref-type="fig"}). We observed that hybridization-based miRNA analyses were less reproducible and that concordance with TaqMan assays varied from target to target. There was a general concordance between the two methods (*R*^2^ = 0.916) for miR-16 across five mouse tissue samples. However, correlations were relatively low for less abundant miRNAs, such as miR-30 (*R*^2^ = 0.751).

Hybridization methods can lack specificity for the mature miRNAs. We investigated the ability of the TaqMan miRNA assays to differentiate between the mature miRNAs and their longer precursors, using synthetic targets for pri-miRNA precursors, pri-miR-26b and pri-let-7a and pre-miRNA precursor pre-miR-30a ([Table 2](#tbl2){ref-type="table"}). TaqMan assays designed to detect either precursors or mature miRNAs were tested with synthetic targets averaging 1.5 × 10^8^ copies per RT reaction (1.3 × 10^7^ copies per PCR). TaqMan miRNA analyses with only pri-miRNA precursor molecules produced *C*~T~ values at least 11 cycles higher than analyses with mature miRNA ones. This result implies that if mature miRNA and precursor were at an equal concentration, the latter would contribute \<0.05% background signal to the assay of mature target. For pre-miR-30a where the mature miRNA miR-30a-3p is located at the 3′ end of the pre-miR-30a sequence, a difference of 8.4 *C*~T~ was observed. The results showed that TaqMan miRNA assays are specific to mature miRNAs. However, the assay specificity is better if the miRNA is located at the 5′ strand of the pre-miRNA precursor. Experiments analyzing total RNA instead of synthetic targets indicated that the precursors are at least two orders of magnitude less abundant than mature miRNAs, based on *C*~T~ differences of 7 or more for miR-26b-1 and let-7a-2 precursors. Considered together, these results suggest that the TaqMan miRNA assays are highly specific for the mature miRNAs.

The ability of the TaqMan miRNA assays to discriminate miRNAs that differ by as little as a single nucleotide was tested with the five synthetic miRNAs of let-7a, let-7b, let-7c, let-7d and let-7e ([Figure 7](#fig7){ref-type="fig"}). Each miRNA assay was examined against each miRNA. Relative detection efficiency was calculated from *C*~T~ differences between perfectly matched and mismatched targets, assuming 100% efficiency for the perfect match. Very low levels of non-specific signal were observed, ranging from zero to 0.3% for miRNAs with 2--3 mismatched bases and only 0.1--3.7% for the miRNAs that differed by a single nucleotide. Most cross-reactions resulted from G--T mismatches during the RT reaction (let-7a assay versus let-7c target etc.). Only the targeted miRNA was detected if more than three mismatched bases between any two miRNAs were present.

We compared the discrimination ability of the TaqMan miRNA assays to that of solution-based hybridization analysis ([Figure 8](#fig8){ref-type="fig"}). In our hands, the hybridization method discriminated well between let-7a and let-7b. However, poor or no discrimination was observed among let-7a, let-7c and let-7d, which differ by 1--3 nt.

We speculated that stem--loop primers might provide better RT efficiency and specificity than linear ones. Base stacking of the stem might enhance the thermal stability of the RNA--DNA heteroduplex. Furthermore, spatial constraint of the stem--loop would likely improve the assay specificity in comparison to conventional linear RT primers. We compared the sensitivity and specificity of the stem--loop and linear RT primers using synthetic miRNAs for let-7a ([Figure 9](#fig9){ref-type="fig"}). We observed several advantages for the stem--loop RT. First, in the presence of the synthetic let-7a target, the *C*~T~ values between linear and stem--loop RT methods differed by 7, indicating that the efficiency of stem--loop RT was at least 100 times higher. Secondly, stem--loop RT discriminated better between miRNAs that differ by two bases based on Δ*C*~T~ values. Finally, the stem--loop RT was at least 100 times better able to discriminate between the mature miRNA and its precursor, based on the Δ*C*~T~ (precursor versus mature) of 7.

DISCUSSION
==========

Since the discovery of miRNAs, remarkable advances in the characterization of these gene families have delineated the mechanism for their functions in gene regulation ([@b35]). As a result, extensive surveys have begun to identify miRNA biomarkers specific for tissue types or disease status. These studies will benefit from methods that allow for both accurate identification and quantification of miRNAs.

Current methods for detection and quantification of miRNAs are largely based on cloning, northern blotting ([@b5]), or primer extension ([@b36]). Although microarrays could improve the throughput of miRNA profiling, the method is relatively limited in terms of sensitivity and specificity ([@b32],[@b33]). Low sensitivity becomes a problem for miRNA quantification because it is difficult to amplify these short RNA targets. Furthermore, low specificity may lead to false positive signal from closely related miRNAs, precursors and genomic sequences. More recently, a modified Invader assay has been reported for the quantification of several miRNAs ([@b37]). However, Invader assays have limited specificity and sensitivity, requiring at least 50 ng total RNA, or 1000 lysed cells, per assay.

Real-time PCR is the gold standard for gene expression quantification ([@b38],[@b39]). It has been a long challenge for scientists to design a conventional PCR assay from miRNAs averaging ∼22 nt in length. We developed a novel scheme to design TaqMan PCR assays that specifically quantify miRNA expression levels with superior performance over existing conventional detection methods. We have designed and validated assays for 222 human miRNAs (Chen *et al*., unpublished data). These assays combine the power of PCR for exquisite sensitivity, real-time monitoring for a large dynamic range and TaqMan assay reporters to increase the specificity. In our hands, miRNA precursors were at least 2000 times less effective targets than mature miRNAs ([Table 2](#tbl2){ref-type="table"}). Because these assays are insensitive to precursors or genomic DNA, we were able to add heat-treated cells directly to the assays, eliminating the need for sample preparation. For applications where both mature miRNAs and their precursors need to be assayed, conventional TaqMan assays can be used in parallel to specifically detected precursors.

We observed the better specificity and sensitivity of stem--loop RT primers than conventional linear ones likely due to the base stacking and spatial constraint of the stem--loop structure ([Figure 9](#fig9){ref-type="fig"}). The base stacking could improve the thermal stability and extend the effective footprint of RT primer/RNA duplex that may be required for effective RT from relatively shorter RT primers. The spatial constraint of the stem--loop structure may prevent it from binding double-strand genomic DNA molecules and, therefore, eliminate the need of TaqMan miRNA assays for RNA sample preparation. Stem--loop RT primers can potentially be used for multiplex RT reactions and small RNA cloning for possibly better efficiency and specificity.

There is an increasing need for sensitive and specific whole miRNA profiling. The ability to effectively profile miRNAs could lead to the discoveries of disease- or tissue-specific miRNA biomarkers, as well as contribute to the understanding of how miRNAs regulate stem cell differentiation. Our stem--loop RT--PCR method should provide a practical solution for these studies. We are currently developing multiplex approaches that should further increase the utility of this method.

SUPPLEMENTARY DATA
==================

Supplementary Data are available at NAR Online.
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![Schematic description of TaqMan miRNA assays, TaqMan-based real-time quantification of miRNAs includes two steps, stem--loop RT and real-time PCR. Stem--loop RT primers bind to at the 3′ portion of miRNA molecules and are reverse transcribed with reverse transcriptase. Then, the RT product is quantified using conventional TaqMan PCR that includes miRNA-specific forward primer, reverse primer and a dye-labeled TaqMan probes. The purpose of tailed forward primer at 5′ is to increase its melting temperature (Tm) depending on the sequence composition of miRNA molecules.](gni178f1){#fig1}

![Dynamic range and sensitivity of the TaqMan lin-4 miRNA assay. (**A**) Amplification plot of synthetic lin-4 miRNA over seven orders of magnitude. Synthetic RNA input ranged from 1.3 × 10^−3^ fM (equivalent to 7 copies per reaction) to 1.3 × 10^4^ fM (7 × 10^7^ copies per reaction) in PCR; (**B**) Standard curve of the lin-4 miRNA.](gni178f2){#fig2}

![Correlation of total RNA input to the threshold of cycle (*C*~T~) values for eight miRNA assays. Mouse lung total RNA input ranged from 0.025 to 250 ng per RT reaction. A *Caenorhabditis elegans* miRNA (miR-2) was included as a negative control assay.](gni178f3){#fig3}

![Dynamic range of eight TaqMan miRNA assays using OP9 cell lysates. The number of cell input ranged from 3 to 2500 cells per RT. A *Caenorhabditis elegans* miRNA (miR-2) was used as a negative control.](gni178f4){#fig4}

![Comparison of heat-treated cells, cell lysate and total RNA for real-time quantitation of 10 miRNAs. The level of miRNA expression is measured in the threshold cycles (*C*~T~). Approximately 400 HepG2 cells were analyzed per PCR.](gni178f5){#fig5}

![Comparison of TaqMan miRNA miR-16 assay to solution-based northern hybridization analysis. Total RNAs from mouse kidney, liver, lung, spleen and testicle tissues were used.](gni178f6){#fig6}

![Discrimination power of let-7 miRNA assays. Relative detection (%) calculated based on *C*~T~ difference between perfectly matched and mismatched targets. A total of 1.5 × 10^8^ copies of synthetic RNA was added to RT reaction. The concentration was estimated based on the *A*~260~ values.](gni178f7){#fig7}

![Poor discrimination of miRNAs with solution hybridization-based (northern) analysis.](gni178f8){#fig8}

![Specificity of TaqMan miRNA assays between stem--loop and linear RT primers. Mature let-7a-specific assay was tested against let-7a, let-7e and pri-miR precursor let-7a-3. Δ*C*~T~ represents the *C*~T~ difference between two targets or methods. A total of 1.5 × 10^8^ copies of synthetic targets were added to each RT reaction.](gni178f9){#fig9}

###### 

Expression profiles of five miRNAs across seven mouse tissues

  miRNA ID   Copy number per cell   cFold-change                                                     
  ---------- ---------------------- -------------- ------ -------- -------- -------- ------ -------- ----
  let-7a     2010                   1420           700    2390     1420     3120     1050   1730     5
  miR-16     10 240                 13 520         3890   22 080   32 090   11 100   5210   14 020   6
  miR-20     70                     300            130    580      1990     420      620    590      28
  miR-21     670                    2540           4450   7970     3550     5310     390    3550     20
  miR-22     290                    1020           310    590      130      560      40     420      26
  Average    2240                   2040           1140   4430     3540     2600     750    2390     17

Mouse or human total RNA samples from brain, heart, liver, lung, thymus, ovary and embryo (at day 10--12) were purchased from Ambion. Copy number per cell is estimated based on standard curve of lin-4 synthetic miRNA. A total of 150 ng RNA (or equivalent to approximately 10 000 cells assuming 15 pg of total RNA per cell) was added to each RT reaction. RNA input was normalized based on TaqMan GAPDH endogenous control (P/N: 4352339E).

###### 

Discrimination between mature miRNAs and their pri- or pre-miRNA precursors

  ID           Synthetic miRNA (No. of copies)   Synthetic precursor (No. of copies)   Total RNA (ng)   *C*~T~ miRNA   Precursor
  ------------ --------------------------------- ------------------------------------- ---------------- -------------- -----------
  miR-26b      1.5 × 10^8^                       0                                     0                16.5           ND
               0                                 1.5 × 10^8^                           0                27.4           18.7
               0                                 0                                     7.5              21.9           28.7
               0                                 0                                     0                ND             ND
  let-7a       1.5 × 10^8^                       0                                     0                16.5           ND
               0                                 1.5 × 10^8^                           0                29.5           19.4
               0                                 0                                     7.5              19.9           34.7
               0                                 0                                     0                ND             ND
  miR-30a-3p   1.5 × 10^8^                       0                                     0                15.8           ND
               0                                 1.5 × 10^8^                           0                24.2           17.2
               0                                 0                                     7.5              25.4           30.3
               0                                 0                                     0                ND             ND
  miR-30a-5p   1.5 × 10^8^                       0                                     0                16.3           ND
               0                                 1.5 × 10^8^                           0                29.1           18.9
               0                                 0                                     7.5              22.1           30.3
               0                                 0                                     0                39.6           ND

Note: ND represents no detectable PCR products after 40 cycles. The copy number of synthetic miRNAs in RT was estimated based on the *A*~260~ values. Only 9% of RT product was added to PCR. Total RNA from human lung was used. Pre-miRNA precursors, pri-let-7a-3 and pri-miR-26b, and pre-miRNA precursor pre-miR-30a were examined.
